Your browser doesn't support javascript.
loading
Apoptosis in megakaryocytes: Safeguard and threat for thrombopoiesis.
Yang, Shuo; Wang, Long; Wu, Yuesong; Wu, Anguo; Huang, Feihong; Tang, Xiaoqin; Kantawong, Fahsai; Anuchapreeda, Songyot; Qin, Dalian; Mei, Qibing; Chen, Jianping; Huang, Xinwu; Zhang, Chunxiang; Wu, Jianming.
Affiliation
  • Yang S; School of Pharmacy, Southwest Medical University, Luzhou, China.
  • Wang L; School of Pharmacy, Southwest Medical University, Luzhou, China.
  • Wu Y; School of Pharmacy, Southwest Medical University, Luzhou, China.
  • Wu A; School of Pharmacy, Southwest Medical University, Luzhou, China.
  • Huang F; Institute of Cardiovascular Research, the Key Laboratory of Medical Electrophysiology, Ministry of Education of China, Medical Key Laboratory for Drug Discovery and Druggability Evaluation of Sichuan Province, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materi
  • Tang X; School of Pharmacy, Southwest Medical University, Luzhou, China.
  • Kantawong F; Institute of Cardiovascular Research, the Key Laboratory of Medical Electrophysiology, Ministry of Education of China, Medical Key Laboratory for Drug Discovery and Druggability Evaluation of Sichuan Province, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materi
  • Anuchapreeda S; School of Pharmacy, Southwest Medical University, Luzhou, China.
  • Qin D; Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
  • Mei Q; Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
  • Chen J; School of Pharmacy, Southwest Medical University, Luzhou, China.
  • Huang X; School of Pharmacy, Southwest Medical University, Luzhou, China.
  • Zhang C; School of Chinese Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.
  • Wu J; School of Chinese Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Front Immunol ; 13: 1025945, 2022.
Article de En | MEDLINE | ID: mdl-36685543
Platelets, generated from precursor megakaryocytes (MKs), are central mediators of hemostasis and thrombosis. The process of thrombopoiesis is extremely complex, regulated by multiple factors, and related to many cellular events including apoptosis. However, the role of apoptosis in thrombopoiesis has been controversial for many years. Some researchers believe that apoptosis is an ally of thrombopoiesis and platelets production is apoptosis-dependent, while others have suggested that apoptosis is dispensable for thrombopoiesis, and is even inhibited during this process. In this review, we will focus on this conflict, discuss the relationship between megakaryocytopoiesis, thrombopoiesis and apoptosis. In addition, we also consider why such a vast number of studies draw opposite conclusions of the role of apoptosis in thrombopoiesis, and try to figure out the truth behind the mystery. This review provides more comprehensive insights into the relationship between megakaryocytopoiesis, thrombopoiesis, and apoptosis and finds some clues for the possible pathological mechanisms of platelet disorders caused by abnormal apoptosis.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Mégacaryocytes / Thrombopoïèse Langue: En Journal: Front Immunol Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Mégacaryocytes / Thrombopoïèse Langue: En Journal: Front Immunol Année: 2022 Type de document: Article Pays d'affiliation: Chine Pays de publication: Suisse